Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer
about
Noncoding RNAs in cancer and cancer stem cellsAllosteric Remodelling of the Histone H3 Binding Pocket in the Pygo2 PHD Finger Triggered by Its Binding to the B9L/BCL9 Co-FactorPygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells.Abnormal expression of Pygopus 2 correlates with a malignant phenotype in human lung cancer.Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing E-cadherin expression.Akt Phosphorylates Wnt Coactivator and Chromatin Effector Pygo2 at Serine 48 to Antagonize Its Ubiquitin/Proteasome-mediated Degradation.Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.Role of Msi1 and PYGO2 in esophageal squamous cell carcinoma depth of invasion.Correlation of Wnt and NOTCH pathways in esophageal squamous cell carcinoma.Wnt signaling in ovarian tumorigenesisA role of Pygopus as an anti-repressor in facilitating Wnt-dependent transcriptionLogical design of an anti-cancer agent targeting the plant homeodomain in Pygopus2Molecular mechanisms of heart failure: insights from DrosophilaEvaluation of cell-line-derived xenograft tumours as controls for immunohistochemical testing for ER and PR.Selective estrogen receptor modulators and betulinic acid act synergistically to target ERα and SP1 transcription factor dependent Pygopus expression in breast cancer.Pygo2 siRNA Inhibit the Growth and Increase Apoptosis of U251 Cell by Suppressing Histone H3K4 Trimethylation.Evidence of a novel role for Pygopus in rRNA transcription.The transcriptional activity of Pygopus is enhanced by its interaction with cAMP-response-element-binding protein (CREB)-binding protein.Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway.The role of Pygo2 for Wnt/ß-catenin signaling activity during intestinal tumor initiation and progression.Downregulation of Pygopus 2 inhibits vascular mimicry in glioma U251 cells by suppressing the canonical Wnt signaling pathway.Association of PYGO2 and EGFR in esophageal squamous cell carcinoma.The role of Pygopus 2 in rat glioma cell growth.Xrel3/XrelA attenuates β-catenin-mediated transcription during mesoderm formation in Xenopus embryos.Abnormal nuclear expression of Pygopus-2 in human primary hepatocellular carcinoma correlates with a poor prognosis.Pygopus 2 promotes kidney cancer OS-RC-2 cells proliferation and invasion in vitro and in vivo.Overexpression of Pygopus2 protects HeLa cells from vinblastine-induced apoptosis.
P2860
Q27011225-47381530-D58F-4546-8E09-F43114B7A291Q27663534-5D6C0FAA-4294-4F2E-BC28-2DAF04E5FBE3Q33709499-CB6B42BE-5F4A-4029-B2AB-E78649C43E2DQ34832587-24B19E01-1CD2-4B47-9C0C-3740090CAF5EQ35098085-13050D32-7858-4778-B00C-5FF2C67657CBQ35781447-DC7A4FB6-E8E4-43D6-B4DC-F0B4D8EC35ADQ35793718-6D650361-22BB-4A55-AD8F-F6ADDF9443CBQ36065109-FD8DC894-64E5-40BF-822D-4E39F0F75D78Q36606033-5662FC41-183E-4803-A28C-9C82BFAD9695Q36849685-688743AE-8A8B-4FB0-8CD2-DB74D152E14AQ36940803-DDBCB2C4-89F2-405D-81D7-CE62F9D1DD40Q36953825-3C653DEB-F7C5-4561-A6C8-31F0430A1DA3Q37039541-53001832-5784-424E-A8FD-AFAD290C3AFBQ37252279-1DA9CEAC-0A77-4D79-BB10-9FD2C15536EBQ37575136-B389587C-1FDA-4293-84F7-8A6E639B1D29Q38385827-157FC966-C194-4D41-BA9F-C6F3291C7D25Q38813726-FA99F45E-0C17-4F8F-BF5A-15846A1036B0Q38887767-8B67CF8B-B87C-4DD3-9C3A-87BBEC4B77CCQ39177701-F254B048-4FCB-481E-9691-DB84FDC4AE0FQ39833272-4F2FEA52-A605-40A7-8E6D-ECAECD232B38Q39997697-F5B70A1D-6DA1-4691-AEA2-1E214BE54F23Q41895615-9F8141CF-78E6-48CB-BE6C-820025DF70BDQ43068054-AEFC2EB0-761D-457E-B7AE-F28516699FF1Q43622554-5EF743AD-4EF4-44F8-9C8E-2833F01A9251Q44669927-DC749CF9-95E9-4ECF-AA61-2B1FCE624B41Q51891800-D7ACE541-D7A5-4284-8D43-BC844C822F7DQ53652147-B8B60D66-F61C-41F6-AC48-F13F530FCA84Q53956465-B180BB6C-2ABF-4B1D-BC4C-E4599B7DB675Q54505414-C2C9BA36-EDA9-4503-99B7-09C86B9439FC
P2860
Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer
@ast
Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer
@en
Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer
@nl
type
label
Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer
@ast
Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer
@en
Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer
@nl
prefLabel
Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer
@ast
Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer
@en
Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer
@nl
P2093
P3181
P1476
Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer
@en
P2093
Blue B Lake
Cathy M Popadiuk
Jieying Xiong
Kenneth R Kao
Kensuke Hirasawa
Kweku Dankwa
Malcolm G Wells
Phillip G Andrews
P304
P3181
P356
10.1158/1078-0432.CCR-05-2433
P407
P433
P577
2006-04-01T00:00:00Z